Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |